 |
Exon 53 specific antisense morpholino oligonucleotide. |
|---|---|
| Trade Name | |
| Orphan Indication | Duchenne muscular dystrophy |
| USA Market Approval | USA |
| USA Designation Date | 2017-01-12 00:00:00 |
| Sponsor | NS Pharma, Inc.;140 East Ridgewood Avenue, Suite 280S;Paramus, New Jersey, 07652 |
